13th Global Drug Delivery & Formulation Summit
March 21-23, 2022
Berlin, Germany

Invited lecture:
Novel Nanotechnologies for Mucosal Delivery of Small Molecules and Biologics: Old Problems but New Solutions
Prof. Dr. A. Bernkop-Schnürch
more...

5th International Conference and Exhibition on Pharmaceutical Science and Technology
June 21-23, 2022
Bangkok, Thailand

Invited lecture:
Lipid-based Nanocarriers for Oral Delivery of Therapeutic Peptides: Hype or Hope?
Prof. Dr. A. Bernkop-Schnürch
more...

ThioMatrix’s drug delivery technologies are mainly based on thiolated polymeric excipients or designated thiomers. Due to the immobilization of thiol groups on already well-established polymeric excipients such as polyacrylates or chitosans the following features are strongly improved:

• mucoadhesive properties more....

• permeation enhancing effect more....

• capability to provide a controlled drug release more....

• enzyme inhibtory properties more....
  
  
• in-situ gelling features more....
  
  
• efflux pump inhibition more....

Self-Emulsifying Drug Delivery Systems

Thiomatrix is also specialized on the design and development of self-nanoemulsifying and self-microemulsifying drug delivery systems (SNEDDS; SMEDDS) collectively summarized as self-emulsifying drug delivery systems (SEDDS). In particular we develop SEDDS providing:

• a protective effect towards a presystemic metabolism more....
  
  
• high mucus permeating properties more....
  
  
• high mucoadhesive properties more....
  
  
• high spreading properties on the mucosa more....
  
  
• permeation enhancing properties more....
  
  

Based on various in-house generated technologies we can incorporate also hydrophilic macromolecular drugs such as therapeutic peptides and DNA/RNA-based drugs in SEDDS.

A. Bernkop-Schnürch, CSO ThioMatrix, was honored with the Gattefossé North America Award 2017
more....